VMocion develops tech to mitigate cybersickness, using its proprietary 3V and WAIV products. 3V, developed in collaboration with Mayo Clinic simulates physical motion for users in virtual, augmented, and mixed reality environments. This is achieved through its WAIV algorithm, which connects to wearable contact points. The technology eliminates motion sickness by sending impulses to the ear's vestibular system, which regulates balance and spatial orientation in the human body.
The company provides a license, reference designs, circuitry, and an SDK to integrate its solutions into head mounted displays (HMDs) such as VR/AR headsets, stereo headphones, and flight simulations. Other applications of 3V include video game consoles, smartphones, and other digital devices. Additionally, its WAIV algorithm can be used to prevent motion sickness in self-driving vehicles, rides at amusement parks, cruise ships, and train rides.
Funding and financials
In January 2024, VMocion raised USD 3 million in a seed funding round, with participation from AZ Crown and Mayo Clinic.
The funds were earmarked to further progress its technology, with Eric Crown of Insight Enterprises also joining the company’s board, alongside VMocion principals and Mayo Clinic.
Competitors: None under coverage (VMocion develops products to mitigate cybersickness in XR environments.)
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.